Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00372411 · ClinicalTrials.gov registry record · Phase 2
Robotic Assisted Upper-Limb Neurorehabilitation in Stroke Patients
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 127
- Enrollment target
NCT00372411: Completed Phase 2 study, sponsored by US Department of Veterans Affairs.
NCT00372411 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 127 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00372411, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 127 participants
- Enrollment target
Study Summary
This study will compare robotic training with usual care and intensive comparison therapy to attempt to improve upper extremity function.
Primary Outcome
Fugl-Meyer (FM) is a standard instrument for the quantitative clinical assessment of motor impairment and function. In this study the upper extremity subsection of the FM was used. The FM assesses several impairment dimensions by using a 3 point ordinal scale: 0 = cannot perform, 1 = can perform partially and 2 = can perform fully. These measures are summed to an overall score is Scoring for upper extremity FM ranges from 0 (worst, completely plegic) to 66 (best, normal). Higher scores indicate
Interventions
- OTHER Usual Care
- DEVICE Robot-Assisted Therapy - MIT-MANUS System
- OTHER Intensive Comparison Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
What the finished NCT00372411 record still lists
NCT00372411 is an interventional study that assigns participants to a tested intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT00372411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00372411 about?
NCT00372411 is a clinical study titled "Robotic Assisted Upper-Limb Neurorehabilitation in Stroke Patients". This study will compare robotic training with usual care and intensive comparison therapy to attempt to improve upper extremity function.
What is the current status of trial NCT00372411?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 127 participants. The study started on 2005-12. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00372411?
The interventions under investigation include: Usual Care (OTHER), Robot-Assisted Therapy - MIT-MANUS System (DEVICE), Intensive Comparison Therapy (OTHER).
Who is sponsoring clinical trial NCT00372411?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00372411's enrollment target sits among peer trials
127 555th of 2000 higher than 1,445 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia